Search

Defect-rich nitrogen-doped biocatalyst (B-NC) was synthesized from natural cellulose of wheat straw using straightforward mechanical method and one-step pyrolysis approach. In contrast to the nitrogen-doped biocatalyst (NC), by leveraging the synergistic effects of nitrogen dopants and surface defects, the microenvironment-modulated B-NC exhibited the enhanced mass transfer efficiency and a significant improvement in reactivity for p-nitrophenol degradation (111 %-196 %). The catalyst's exceptional performance primarily arose from graphitic N, pyridinic N and CO active sites, which mainly derived from the cellulose structure of wheat straw and nitrogen dopants. Electron paramagnetic resonance and quenching tests confirmed that the B-NC/peroxymonosulfate system generated more reactive species (SO 4 • - , •OH, O 2 • - , and 1 O 2 ) during p-nitrophenol degradation, surpassing the NC/peroxymonosulfate system. Additionally, both density functional theory calculations and electrochemical experiments provided evidence of peroxymonosulfate strongly adsorbing onto B-NC's defect sites, facilitating the formation of catalyst/peroxymonosulfate* complexes and promoting electron transfer processes. This research provides valuable insights into the regulation of defects in nitrogen-doped biocatalyst derived from natural cellulose, presenting a promising solution for remediating refractory organic pollutants., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)

Background: The benefits of transcranial direct current stimulation (tDCS) for patients with major depression disorders are well-established, however, there is a notable research gap concerning its comprehensive effects on both depressive symptoms and cognitive functions. Existing research is inconclusive regarding the cognitive enhancement effects of tDCS specifically in MDD patients. The present study aims to fill this knowledge gap by scrutinizing the most updated evidence on the effectiveness of tDCS in anti-depressive treatment and its influence on cognitive function., Methods: A systematic review was performed from the first date available in PubMed, EMBASE, Cochrane Library, and additional sources published in English from 1 January 2001 to 31 May 2023. We examined cognitive outcomes from randomized, sham-controlled trials of tDCS treatment for major depression. The evaluation process strictly followed the Cochrane bias risk assessment tool into the literature, and meta-analysis was performed according to the Cochrane System Reviewer's Manual., Results: In this quantitative synthesis, we incorporated data from a total of 371 patients across 12 studies. Results showed significant benefits following active tDCS compared to sham for the antidepressant effect [SMD: -0.77 (-1.44, -0.11)]. Furthermore, active relative to sham tDCS treatment was associated with increased performance gains on a measure of verbal memory [SMD: 0.30 (-0.02, 0.62)]. These results did not indicate any cognitive enhancement after active tDCS relative to sham for global cognitive function, whereas there was a noticeable trend toward statistical significance specifically in the effect of verbal memory., Conclusions: Our study offers crucial evidence-based medical support for tDCS in antidepressant and dimension-specific cognitive benefits. Further well-designed, large-scale randomized sham-controlled trials are warranted to further validate these findings., Systematic Review Registration: https://inplasy.com/, identifier: INPLASY202360008., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Wang, Yao, Ji and Li.)